We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generics Makers Claim Vindication in FTC Report
Generics makers are claiming vindication after a Federal Trade Commission report found only a single patent case was settled with “pay-for-delay” tactics in fiscal 2016—the lowest level since the government began tracking such settlements.